XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Balance at Dec. 31, 2017 $ 85,583 $ 977 $ 17,881 $ (4,397) $ 100,044
Balance (in shares) at Dec. 31, 2017 11,630,129        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     12,551   12,551
Other comprehensive income (loss), net of tax       (639) (639)
Stock dividend adjustment $ 240   (240)   0
Stock dividend adjustment (in shares) 628        
Stock dividend declared $ 6,280   (6,280)   0
Stock dividend declared (in shares) 583,514        
Cash in lieu of fractional shares     (10)   (10)
Cash in lieu of fractional shares (in shares) (159)        
Stock-based compensation $ 424       424
Common shares issued related to restricted stock grants and ESPP, net of restricted stock reversals $ 91       91
Common shares issued related to restricted stock grants and ESPP, net of restricted stock reversals (in shares) 33,722        
Stock options exercised, net $ 0       0
Stock options exercised, net (in shares) 5,978        
Balance at Dec. 31, 2018 $ 92,618 977 23,902 (5,036) 112,461
Balance (in shares) at Dec. 31, 2018 12,253,812        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     14,721   14,721
Other comprehensive income (loss), net of tax       5,170 5,170
Stock dividend adjustment $ 330   (330)   0
Stock dividend adjustment (in shares) 1,401        
Stock dividend declared $ 6,668   (6,668)   0
Stock dividend declared (in shares) 615,196        
Cash in lieu of fractional shares     (8)   (8)
Cash in lieu of fractional shares (in shares) (116)        
Stock-based compensation $ 475       475
Common shares issued related to restricted stock grants and ESPP, net of restricted stock reversals $ 96       96
Common shares issued related to restricted stock grants and ESPP, net of restricted stock reversals (in shares) 48,839        
Balance at Dec. 31, 2019 $ 100,187 977 31,617 134 132,915
Balance (in shares) at Dec. 31, 2019 12,919,132        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     12,161   12,161
Other comprehensive income (loss), net of tax       4,904 4,904
Stock dividend adjustment $ 348   (348)   0
Stock dividend adjustment (in shares) 1,310        
Stock dividend declared $ 6,307   (6,307)   0
Stock dividend declared (in shares) 649,260        
Cash in lieu of fractional shares     (8)   (8)
Cash in lieu of fractional shares (in shares) (166)        
Stock-based compensation $ 574       574
Common shares issued related to restricted stock grants and ESPP, net of restricted stock reversals $ 111       111
Common shares issued related to restricted stock grants and ESPP, net of restricted stock reversals (in shares) 51,993        
Stock options exercised, net $ 0       0
Stock options exercised, net (in shares) 12,934        
Balance at Dec. 31, 2020 $ 107,527 $ 977 $ 37,115 $ 5,038 $ 150,657
Balance (in shares) at Dec. 31, 2020 13,634,463